Prognostic value of heart failure hospitalization in transthyretin cardiac amyloidosis: an international cohort study
HFH is independently associated with all-cause mortality in patients with TTR-CA and has incremental value on top of established risk models.
Authors
- Philippe Debonnaire (ORCID: https://orcid.org/0000-0003-1196-3016)
- Dorien Laenens (ORCID: https://orcid.org/0000-0001-8906-2395)
- Steven Droogmans (ORCID: https://orcid.org/0000-0003-3985-3249)
- Ruxandra Jurcuţ (ORCID: https://orcid.org/0000-0002-3438-2612)
- Nicole Sturkenboom (ORCID: https://orcid.org/0000-0003-3826-5541)
- Takeru Nabeta (ORCID: https://orcid.org/0000-0003-4671-7667)
- Idit Yedidya (ORCID: https://orcid.org/0000-0002-3012-275X)
- Brito Dulce
- P Bertrand
- N Van de Veire
- F Pinto
- N Ajmone Marsan
- E Donal
- F H Verbrugge
- C H Sia
- J J Bax
- A C T Ng
- M A J De Smet
Institutions
- Vrije Universiteit Brussel (BE)
- University of Lisbon (PT)
- University of Turku (FI)
- Tel Aviv University (IL)
- Leiden University Medical Center (NL)
- Rabin Medical Center (IL)
- Turku University Hospital (FI)
- Cardiovascular Institute Hospital (JP)
- Université Rennes 2 (FR)
- UNSW Sydney (AU)
- Antwerp University Hospital (BE)
- National University Heart Centre Singapore (SG)
- AZ Sint-Jan (BE)
- Sint Maartenskliniek (NL)
- National Institute of Cardiovascular Diseases (PK)
- AZ Maria Middelares (BE)
- National Institute of Cardiovascular Diseases (BD)
- Ziekenhuis Oost-Limburg (BE)
- Centre Hospitalier Universitaire de Rennes (FR)
- Université de Rennes (FR)
- Kitasato University (JP)
Publication Details
- Journal
- ESC Heart Failure
- Published
- 2026-01-08
- DOI
- https://doi.org/10.1093/eschf/xvaf013
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00